Company research / COO

Cooper Companies, Inc. (COO)

SEC name COOPER COMPANIES, INC. · CIK 0000711404 · Nasdaq · Ophthalmic Goods

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Oct 31

For the year ended 2025-10-31, Cooper Companies, Inc. reported revenue of $4.09B. Revenue grew 5.1% from the prior annual period. Over the twelve months to 2026-07-31, revenue was $4.24B.

Key ratios (year ended 2025-10-31)

65.5%
Gross margin
16.7%
Operating margin
9.2%
Net margin
4.6%
Return on year-end equity
5.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-17

Headquarters locality: San Ramon · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-07-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Stock splits: 4-for-1, first reflected in a filing dated 2024-03-01. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period endedTTM to
2026-07-31
2025-10-312024-10-312023-10-312022-10-312021-10-312020-10-312019-10-312018-10-312017-10-312016-10-31
Revenue$4.24B$4.09B$3.90B$3.59B$3.31B$2.92B$2.43B$2.65B$2.53B$2.14B$1.97B
Cost of Revenue$1.44B$1.41B$1.30B$1.24B$1.17B$966.70M$896.10M$896.60M$900.50M$773.20M$793.70M
Gross Profit$2.79B$2.68B$2.60B$2.36B$2.14B$1.96B$1.53B$1.76B$1.63B$1.37B$1.17B
R&D Expense$169.80M$172.20M$155.10M$137.40M$110.30M$92.70M$93.30M$86.70M$84.80M$69.20M$65.40M
Operating Income$544.20M$682.90M$705.70M$533.10M$507.60M$505.80M$311.80M$546.70M$403.10M$429.10M$324.10M
Depreciation & Amortization$384.00M$377.40M$375.10M$367.70M$346.10M$309.30Mn/a$280.80M$275.10M$188.40M$198.30M
EBITDA$928.20M$1.06B$1.08B$900.80M$853.70M$815.10Mn/a$827.50M$678.20M$617.50M$522.40M
Net Income$570.30M$374.90M$392.30M$294.20M$385.80M$2.94B$238.40M$466.70M$139.90M$372.90M$273.90M
EPS (Diluted)n/a$1.87$1.96$1.48$1.94$59.16$4.81$9.33$2.81$7.52$5.59
Total Assets$12.67B$12.39B$12.32B$11.66B$11.49B$9.61B$6.74B$6.27B$6.11B$4.86B$4.48B
Total Liabilities$4.34B$4.16B$4.23B$4.11B$4.32B$2.66B$2.91B$2.65B$2.81B$1.68B$1.78B
Shareholders' Equity$8.33B$8.24B$8.08B$7.55B$7.17B$6.94B$3.82B$3.63B$3.31B$3.18B$2.70B
Cash & Equivalents$154.70M$110.60M$107.60M$120.80M$138.20M$95.90M$115.90M$89.00M$77.70M$88.80M$100.80M
Operating Cash Flow$1.03B$796.10M$709.30M$607.50M$692.40M$738.60M$486.60M$713.20M$668.90M$593.60M$509.60M
Capital Expenditures$355.30M$362.40M$421.20M$392.50M$242.00M$214.40M$310.40M$292.10M$193.60M$127.20M$152.60M
Free Cash Flow$678.00M$433.70M$288.10M$215.00M$450.40M$524.20M$176.20M$421.10M$475.30M$466.40M$357.00M
Share Repurchases$644.00M$290.10M$0$0$78.50M$24.80M$47.80M$156.10M$0$55.00M$0
Dividends Paidn/a$0$0$3.00M$3.00M$3.00M$3.00M$3.00M$2.90M$2.90M$2.90M
Shares Outstanding190.10M195.90M199.60M198.10M49.30M49.30M49.10Mn/an/an/an/a
Dividends Per Sharen/an/an/a$0.03$0.03$0.03$0.03$0.03$0.03$0.03$0.03
Weighted Average Diluted Sharesn/a200.00M200.40M199.30M198.80M49.80M49.60M50.00M49.70M49.60M49.00M
EPS (Basic)n/a$1.88$1.97$1.49$1.95$59.80$4.85$9.44$2.85$7.63$5.65

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView